SuperGen to Present at the Rodman & Renshaw 10th Annual Healthcare Conference on November 10, 2008
November 03 2008 - 1:08PM
PR Newswire (US)
DUBLIN, Calif., Nov 3 /PRNewswire-FirstCall/ -- SuperGen, Inc.
(NASDAQ: SUPG), a pharmaceutical company dedicated to the discovery
and development of novel cancer therapies, today announced that
James S. Manuso, Ph.D., President and Chief Executive Officer, is
scheduled to present at the Rodman & Renshaw 10th Annual
Healthcare Conference on Monday, November 10, 2008, at the New York
Palace Hotel. SuperGen's presentation at the Rodman & Renshaw
10th Annual Healthcare Conference is scheduled to begin at 11:35
a.m. EDT (8:35 a.m. PDT). A live webcast of the presentation will
be available on the investor relations section of the Company's Web
site at http://www.supergen.com/. The webcast will be archived for
90 days. About SuperGen Based in Dublin, Calif., SuperGen, Inc. is
a pharmaceutical company dedicated to the discovery and development
of novel cancer therapies. SuperGen is developing a number of
therapeutic anticancer products focused on kinase and cell
signaling inhibitors and DNA methyltransferase inhibitors. For more
information about SuperGen, please visit http://www.supergen.com/.
Contacts: SuperGen, Inc. Timothy L. Enns SVP, Corporate
Communications & Business Development Tel: (925) 560-0100
Email: Mary M. Vegh Manager, Investor Relations Tel: (925) 560-2845
E-mail: Dorland Global Public Relations Michael Beckerich (Media)
Tel: (212) 677-7632 DATASOURCE: SuperGen, Inc. CONTACT: Timothy L.
Enns, SVP of Corporate Communications & Business Development,
+1-925-560-0100, , or Mary M. Vegh, Manager, Investor Relations,
+1-925-560-2845, , both of SuperGen, Inc., or Michael Beckerich of
Dorland Global Public Relations, +1-212-677-7632, Web Site:
http://www.supergen.com/
Copyright